NCT06125951: Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 247 taking part
- Started
- 12 Apr 2024
- Primary completion
- 22 Sep 2026
- Arms
- 10 mg Xanamem, Open label phase
- Results
- None posted
- 9 Nov 2023: Trial registered
- 12 Apr 2024: Trial started